During the past decade, Catawba Research, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Catawba Research, LLC" are "Acne Vulgaris" (7 trials), "Plaque Psoriasis" (2 trials), "Rosacea" (1 trials), "Scalp Psoriasis" (1 trials) and "Tinea Pedis" (1 trials). Many other conditions were trialed in "Catawba Research, LLC" in a lesser frequency.

Most popular intervention types in "Catawba Research, LLC" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Control" (3 trials), "Vehicle of the test product" (3 trials), "Placebo" (2 trials), "Adapalene Gel 0.1%" (1 trials) and "Azelaic acid foam 15%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Catawba Research, LLC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Catawba Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Catawba Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Catawba Research, LLC, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".